Rankings
▼
Calendar
SCYX Q3 2016 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena
SCYX
SCYNEXIS, Inc.
$38M
Q3 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$64,000
Gross Profit
$64,000
100.0% margin
Operating Income
-$7M
-10478.1% margin
Net Income
-$11M
-17543.8% margin
EPS (Diluted)
$-4.79
QoQ Revenue Growth
+0.0%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$292,000
Balance Sheet
Total Assets
$61M
Total Liabilities
$28M
Stockholders' Equity
$33M
Cash & Equivalents
$30M
← FY 2016
All Quarters
Q4 2016 →